Preview

Rational Pharmacotherapy in Cardiology

Advanced search

ANTIAGGREGANT THERAPY OVERCOMES LIMITS

Full Text:

Abstract

Antiaggregant therapy overcomes limits.

About the Author

I. Andreeva

Russian Federation


References

1. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. Br. Med. J. 2002;324:71-86

2. COMMIT Collaborative Grioup. Addition of clopidogrel to aspirin in 45852 patients with acute myocardial infarction: randomized placebo–controlled trial. Lancet 2005; 366: 1607-21

3. CLARITY-TIMI 28 Investigators. Addition of clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation. N.England J.Med. 2005;352:1179-1189

4. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of schaemic events (CAPRIE). Lancet 1996;348:1329-1339


For citation:


Andreeva I. ANTIAGGREGANT THERAPY OVERCOMES LIMITS. Rational Pharmacotherapy in Cardiology. 2009;5(5):93-95. (In Russ.)

Views: 295


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)